Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome

Novartis

Status and phase: Completed; Phase 4

Conditions: Metabolic Syndrome

Treatments: Drug: Fluvastatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00138528

CXUO320BDE30

Details and patient eligibility

About

Other effects of fluvastatin are investigated in German patients with metabolic syndrome.

Enrollment: 55 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Written informed consent
• Male and female patients, aged between 18 and 75 years
• Metabolic syndrome according to National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII)

Exclusion criteria

• History of heart failure
• HIV positive
• Stroke

Other protocol defined inclusion and exclusion criteria may apply.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind